GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lifecome Biochemistry Co Ltd (SZSE:002868) » Definitions » Forward PE Ratio

Lifecome Biochemistry Co (SZSE:002868) Forward PE Ratio : 0.00 (As of May. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lifecome Biochemistry Co Forward PE Ratio?

Lifecome Biochemistry Co's Forward PE Ratio for today is 0.00.

Lifecome Biochemistry Co's PE Ratio without NRI for today is 0.00.

Lifecome Biochemistry Co's PE Ratio for today is 0.00.


Lifecome Biochemistry Co Forward PE Ratio Historical Data

The historical data trend for Lifecome Biochemistry Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecome Biochemistry Co Forward PE Ratio Chart

Lifecome Biochemistry Co Annual Data
Trend
Forward PE Ratio

Lifecome Biochemistry Co Quarterly Data
Forward PE Ratio

Competitive Comparison of Lifecome Biochemistry Co's Forward PE Ratio

For the Biotechnology subindustry, Lifecome Biochemistry Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecome Biochemistry Co's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lifecome Biochemistry Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Lifecome Biochemistry Co's Forward PE Ratio falls into.



Lifecome Biochemistry Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Lifecome Biochemistry Co  (SZSE:002868) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Lifecome Biochemistry Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Lifecome Biochemistry Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecome Biochemistry Co (SZSE:002868) Business Description

Traded in Other Exchanges
N/A
Address
No.19, Nanpu Ecological Industrial Park, Pucheng, Fujian, CHN, 353400
Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.
Executives
Lou Li Jun Supervisors
Huang Hui Executives
Bao Zhong Shou Executives
Feng Zhen Wu Supervisors
Li Jun Hui Executives
Lai Tan Ping Directors, executives
Xu Chun Lin Director
Lai Jian Ping Directors, executives

Lifecome Biochemistry Co (SZSE:002868) Headlines

No Headlines